Can urine tests reveal the best diet for breast cancer survivors?

NCT ID NCT07655934

Recruiting now Knowledge-focused Sponsor: Abramson Cancer Center at Penn Medicine Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

The MILES Study is tracking 100 women recently diagnosed with early-stage breast cancer to see how their diet and physical activity change over time. Participants fill out surveys and provide urine samples, which researchers analyze for chemical markers. The goal is to develop simple, reliable tools that clinics can use to help survivors stick with healthy habits.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this study could point toward simple, scalable tools to help breast cancer survivors adopt healthier lifestyles during and after treatment.
What could go wrong: This is an observational study, not a treatment trial. It will not test a drug or therapy, so it cannot directly improve health outcomes on its own.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast cancer breast neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BREAST CANCER

Contacts and locations

Show contact details

Locations

Abamson Cancer Center of the University of Pennsylvania
RECRUITING

Philadelphia, Pennsylvania, 19104, United States

Contact Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.